Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by patients with cystic fibrosis

作者: Kavitha Nadesalingam , Steven P. Conway , Miles Denton

DOI: 10.1016/J.JCF.2004.09.002

关键词:

摘要: Abstract Methicillin-resistant Staphylococcus aureus (MRSA) is an increasing problem for patients with cystic fibrosis (CF). It has been associated clinical deterioration in some CF, creates additional infection control problems, and may affect acceptance onto transplant waiting lists. Recent attempts to eradicate the organism have met only moderate success. An understanding of those factors which increase risk acquisition MRSA by CF will aid development effective preventative strategies. We conducted a retrospective case-control study comparing variety 15 MRSA-positive 30 age-sex-matched MRSA-negative controls who attended Regional Paediatric or Adult Cystic Fibrosis Units Leeds. During year prior initial isolation, spent more days hospital (mean 19.8 versus 5.5 days, p =0.0003), received treatment oral ciprofloxacin (43.5 13.9 =0.03) oral/intravenous cephalosporins (42.7 15.4 =0.04) were likely be chronically infected Aspergillus fumigatus (40% 10%, than controls. There no significant differences observed parameters (clinical X-ray scores) between two groups. Minimising number length admissions judicious use antibiotics, particularly ciprofloxacin, should key components any strategies designed reduce CF.

参考文章(25)
S. Stefani, P.E. Varaldo, Epidemiology of methicillin-resistant staphylococci in Europe. Clinical Microbiology and Infection. ,vol. 9, pp. 1179- 1186 ,(2003) , 10.1111/J.1469-0691.2003.00698.X
S.R. Thomas, K.M. Gyi, H. Gaya, M.E. Hodson, Methicillin-resistant Staphylococcus aureus: impact at a national cystic fibrosis centre Journal of Hospital Infection. ,vol. 40, pp. 203- 209 ,(1998) , 10.1016/S0195-6701(98)90138-4
H. von Baum, C. Schmidt, D. Svoboda, O. Bock-Hensley, Constanze Wendt, Risk factors for methicillin-resistant Staphylococcus aureus carriage in residents of German nursing homes. Infection Control and Hospital Epidemiology. ,vol. 23, pp. 511- 515 ,(2002) , 10.1086/502098
Bernard Boxerbaum, Michael R. Jacobs, Ronald L. Cechner, Prevalence and significance of methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis. Pediatric Pulmonology. ,vol. 4, pp. 159- 163 ,(1988) , 10.1002/PPUL.1950040307
A. Solís, D. Brown, J. Hughes, H.K.F. van Saene, D.P. Heaf, Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: An eradication protocol. Pediatric Pulmonology. ,vol. 36, pp. 189- 195 ,(2003) , 10.1002/PPUL.10231
Gerald Dziekan, Axel Hahn, Karina Thüne, Guido Schwarzer, Konrad Schäfer, Franz D. Daschner, Hajo Grundmann, Methicillin-resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study Journal of Hospital Infection. ,vol. 46, pp. 263- 270 ,(2000) , 10.1053/JHIN.2000.0846
Natasha S. Crowcroft, Olivier Ronveaux, Dominique L. Monnet, Raf Mertens, Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals. Infection Control and Hospital Epidemiology. ,vol. 20, pp. 31- 36 ,(1999) , 10.1086/501555
A. Voss, D. Milatovic, C. Wallrauch-Schwarz, V. T. Rosdahl, I. Braveny, Methicillin-Resistant Staphylococcus aureus in Europe European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 13, pp. 50- 55 ,(1994) , 10.1007/BF02026127
L.A Garske, T.J Kidd, R Gan, J.P Bunting, C.A Franks, C Coulter, P.J Masel, S.C Bell, Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection. Journal of Hospital Infection. ,vol. 56, pp. 208- 214 ,(2004) , 10.1016/J.JHIN.2003.12.003
Harris R. Stutman, Jay M. Lieberman, Eliezer Nussbaum, Melvin I. Marks, Antibiotic prophylaxis in infants and young children with cystic fibrosis: A randomized controlled trial The Journal of Pediatrics. ,vol. 140, pp. 299- 305 ,(2002) , 10.1067/MPD.2002.121930